ClinicalTrials.Veeva

Menu

Imaging of Vitreous Opacities in Human Eyes

P

PulseMedica

Status

Completed

Conditions

Vitreous Opacities
Floaters

Treatments

Device: SVO-ID

Study type

Interventional

Funder types

Industry

Identifiers

NCT06097897
SVO-IDFIH001

Details and patient eligibility

About

Vitreous opacities (VOs), commonly known as floaters, are dark spots that appear in, and may float across your vision. Presently, there is a lack of available data in the literature regarding VOs. This study aims to obtain imaging data of VOs in the population to build an imaging database of VOs to learn more about them.

Enrollment

91 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 18 years or older
  • SVO-related symptoms in vision
  • Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

Exclusion criteria

  • Presence of vitreous hemorrhage
  • Cataract Grade 3 and above
  • Opacification of lens, cornea, or vitreous
  • Diagnosis of narrow-angle glaucoma
  • Refractive error is outside the range of -6D to +3D
  • Astigmatism is outside the range of +/- 2D of cylinder

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

91 participants in 1 patient group

Imaging using the SVO-ID
Experimental group
Description:
Patients will have their eyes imaged with the SVO-ID as part of a study visit.
Treatment:
Device: SVO-ID

Trial contacts and locations

1

Loading...

Central trial contact

Study Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems